GENELUX Corp — Director's Dealing 2023

Jan 26, 2023

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: GENELUX CORP (GNLX)
CIK: 0001231457
Period of Report: 2023-01-25

Reporting Person: Woodward Gabe (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series I Preferred Stock	$		Common Stock (5378)		Indirect
Series J Preferred Stock	$		Common Stock (3186)		Direct
Series K Preferred Stock	$		Common Stock (2798)		Indirect
Stock Option (right to buy)	$9.00	2027-11-21	Common Stock (8333)		Indirect
Stock Option (right to buy)	$9.00	2028-02-21	Common Stock (8333)		Indirect
Stock Option (right to buy)	$9.00	2028-05-21	Common Stock (8333)		Indirect
Stock Option (right to buy)	$9.00	2028-08-21	Common Stock (8333)		Indirect
Stock Option (right to buy)	$10.50	2032-09-08	Common Stock (25000)		Direct

Footnotes

F1: The Series I Preferred Stock has no expiration date and will automatically convert into shares of Common Stock at a conversion ratio of 1.241082248 shares of Common Stock for each 3 shares of Series I Preferred Stock for no additional consideration upon the closing of the Issuer's initial public offering.

F2: The Series J Preferred Stock has no expiration date and will automatically convert into shares of Common Stock at a conversion ratio of 1.36557561 shares of Common Stock for each 3 shares of Series J Preferred Stock for no additional consideration upon the closing of the Issuer's initial public offering.

F3: The Series K Preferred Stock has no expiration date and will automatically convert into shares of Common Stock at a conversion ratio of 1.399411327 shares of Common Stock for each 3 shares of Series K Preferred Stock for no additional consideration upon the closing of the Issuer's initial public offering.

F4: By Gabe Woodward, Trustee of The Gabe and Staci Woodward Family Trust dated June 5, 2009.

F5: Immediately exercisable.